Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan-Feb;87(1):116-119.
doi: 10.4103/ijdvl.IJDVL_124_20.

Intramatricial low-dose secukinumab injection for nail psoriasis

Fang He  1 , FangYuan Long  1 , Jie Tu  1 , ZhiQiang Yin  1
Affiliations
Free article
Case Reports

Intramatricial low-dose secukinumab injection for nail psoriasis

Fang He et al. Indian J Dermatol Venereol Leprol. 2021 Jan-Feb.
Free article
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Reich K, Sullivan J, Arenberger P, Mrowietz U, Jazayeri S, Augustin M, et al. Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial. Br J Dermatol. 2019; 181:954-66 - DOI - PubMed
    1. Mittal J, Mahajan BB. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine. Indian J Dermatol Venereol Leprol. 2018; 84:419-23 - DOI - PubMed
    1. Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003; 49:206-12 - DOI

LinkOut - more resources